Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Filensin Antibody (OTI2B2), PerCP, Novus Biologicals™
SDP

Catalog No. NB289706 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB289706 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB289706 Supplier Novus Biologicals Supplier No. NBP270249PCP
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

Filensin Monoclonal antibody specifically detects Filensin in Human samples. It is validated for Western Blot, Immunohistochemistry

Specifications

Antigen Filensin
Applications Western Blot, Immunohistochemistry
Classification Monoclonal
Clone OTI2B2
Conjugate PerCP
Dilution Western Blot, Immunohistochemistry
Formulation PBS
Gene Alias Beaded filament structural protein 1, beaded filament structural protein 1, filensin, CP115Lens intermediate filament-like heavy, filensin, Lens fiber cell beaded-filament structural protein CP 115, LIFL-H115 KD
Host Species Mouse
Immunogen Human recombinant protein fragment corresponding to amino acids 405-665 of human BFSP1 (NP_001186) produced in E.coli.
Purification Method Immunogen affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Vision
Primary or Secondary Primary
Gene ID (Entrez) 631
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.